Philipp Freese
Corporate Officer/Principal bei MAINZ BIOMED N.V.
Vermögen: 372 831 $ am 31.03.2024
Profil
Philipp Freese has held the following positions in his career: Co-Managing Director at PharmGenomics GmbH since 2013 and Chief Business Officer at Mainz Biomed NV since 2015.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAINZ BIOMED N.V.
2,16% | 26.03.2024 | 361 972 ( 2,16% ) | 372 831 $ | 31.03.2024 |
Aktive Positionen von Philipp Freese
| Unternehmen | Position | Beginn |
|---|---|---|
| MAINZ BIOMED N.V. | Corporate Officer/Principal | 01.07.2023 |
PharmGenomics GmbH
 PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Chief Executive Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MAINZ BIOMED N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
PharmGenomics GmbH
PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Health Technology |
